Jeff Benck Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 7 hours ago
Jeff Benck has an estimated net worth of at least $18.5 million*, as of April 2, 2025. They own 448,180 shares of BHE stock. They have sold 36,000 shares of BHE stock since 2021, for an estimated $1.5 million.
Jeff Benck $BHE SEC Form 4 Insider Trading
Jeff Benck has filed a total of 6 insider trades in $BHE since 2021. Their most recent trade was a sale of 6,000 shares, made on Mar 12, 2025. Their largest trade was a sale of 24,000 shares, made on Nov 05, 2024. We estimate that they now own 448,180 shares of $BHE, worth an estimated $17.0 million.
Insider Trading at $BHE
There have been a total of 20 insider trades reported at $BHE since 2021, with 11,284 shares purchased and 124,965 shares sold. The most active insider traders in $BHE stock have been Jeff Benck, Rhonda R Turner, and Jan M Janick. The most recent trade was a sale of 6,000 shares reported by Jeff Benck (President and CEO), made on Mar 12, 2025.
History of Insider Stock Trades by Jeff Benck
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 6,000 | Mar 12, 2025 | March 13, 2025, 3:05 p.m. |
![]() |
Sale | 6,000 | Jan 13, 2025 | Jan. 15, 2025, 5:01 p.m. |
![]() |
Sale | 24,000 | Nov 05, 2024 | Nov. 7, 2024, 12:28 p.m. |
![]() |
Purchase | 2,100 | May 04, 2022 | May 4, 2022, 8:15 p.m. |
![]() |
Purchase | 1,500 | Nov 30, 2021 | Nov. 30, 2021, 3:58 p.m. |
![]() |
Purchase | 1,900 | Aug 06, 2021 | Aug. 5, 2021, 8 p.m. |
$BHE Executives and Stock Owners with Insider Trades
-
Jeff Benck, President and CEO
-
Rhonda R Turner, SVP, Chief HR Officer
-
Jan M Janick, SVP, Chief Technology Officer
-
Roop Kalyan Lakkaraju, EVP, Chief Financial Officer
-
Arvind Kamal, Interim CFO
-
Stephen J Beaver, SVP, General Counsel and CLO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.